Novel complementary peptides to target molecules
- PMID: 21873168
Novel complementary peptides to target molecules
Abstract
We generated an evolutionary computer program that generates complementary peptide (C-pep) sequences, with the potential to interact with a target peptide, by comparing several physico-chemical parameters of each pair of the complementary peptides being analyzed. We generated C-peps to target several molecules. About 30% of synthesized C-peps interfered with the function of their targets. C5a stimulates generation of TNFα and other inflammatory cytokines. Inhibition of C5a should be effective against sepsis, which impairs the status of cancer-bearing patients. One of the inhibitory C-peps of C5a, termed AcPepA, was effective in Cynomolgus monkeys intravenously infused with a lethal dose of bacterial LPS (4 mg/kg) destined to die. The monkeys were rescued by intravenous administration of 2 mg/kg/h of AcPepA. The excellent therapeutic effect of AcPepA is likely to be due to restriction of high mobility group box 1 (HMGB1) surge induced by the effect of C5a on C5L2, which is the second C5a receptor, since the released HMGB1 has the capacity to stimulate TLR4 as an endogeneous ligand resulting in further activation of inflammatory cells to release inflammatory cytokines forming a positive feedback circuit of inflammation.
Similar articles
-
Antisense homology boxes in C5a receptor and C5a anaphylatoxin: a new method for identification of potentially active peptides.J Immunol. 1996 Nov 15;157(10):4591-601. J Immunol. 1996. PMID: 8906838
-
The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.J Immunol. 2010 Feb 1;184(3):1492-8. doi: 10.4049/jimmunol.0902660. Epub 2009 Dec 18. J Immunol. 2010. PMID: 20028656
-
[Advances in research of the roles of C5a-C5L2, high mobility group B1 and Toll like receptor 4 in sepsis].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Feb;27(2):155-7. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015. PMID: 25665619 Chinese. No abstract available.
-
HMGB1 as a cytokine and therapeutic target.J Endotoxin Res. 2002;8(6):469-72. doi: 10.1179/096805102125001091. J Endotoxin Res. 2002. PMID: 12697092 Review.
-
HMGB1 as a DNA-binding cytokine.J Leukoc Biol. 2002 Dec;72(6):1084-91. J Leukoc Biol. 2002. PMID: 12488489 Review.
Cited by
-
Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice.PLoS One. 2013 Apr 22;8(4):e60795. doi: 10.1371/journal.pone.0060795. Print 2013. PLoS One. 2013. PMID: 23630572 Free PMC article.
-
Targeting the hedgehog signaling pathway with interacting peptides to Patched-1.J Gastroenterol. 2012 Apr;47(4):452-60. doi: 10.1007/s00535-011-0507-6. Epub 2011 Dec 15. J Gastroenterol. 2012. PMID: 22170414
-
Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys.Clin Infect Dis. 2015 Feb 15;60(4):586-95. doi: 10.1093/cid/ciu887. Epub 2014 Nov 27. Clin Infect Dis. 2015. PMID: 25433014 Free PMC article.
-
Interaction of Human C5a with the Major Peptide Fragments of C5aR1: Direct Evidence in Support of "Two-Site" Binding Paradigm.ACS Omega. 2021 Aug 26;6(35):22876-22887. doi: 10.1021/acsomega.1c03400. eCollection 2021 Sep 7. ACS Omega. 2021. PMID: 34514259 Free PMC article.
-
C5a inhibitor protects against ischemia/reperfusion injury in rat small intestine.Microbiol Immunol. 2016 Jan;60(1):35-46. doi: 10.1111/1348-0421.12338. Microbiol Immunol. 2016. PMID: 26576826 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous